Harrow Health, Inc.
(NASDAQ : IMMY)

( )
IMMY PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
0.16%18.421.8%$132.46m
ICPTIntercept Pharmaceuticals, Inc.
4.05%90.5318.6%$94.99m
SAGESAGE Therapeutics, Inc.
0.89%166.988.8%$82.15m
JAZZJazz Pharmaceuticals Plc
3.03%129.782.3%$71.68m
GWPHGW Pharmaceuticals PLC Sponsored ADR
2.21%165.566.3%$60.71m
PRGOPerrigo Co. Plc
0.38%49.756.8%$54.82m
ZGNXZogenix, Inc.
0.48%37.399.9%$45.65m
UTHRUnited Therapeutics Corporation
5.53%104.3114.3%$44.47m
CTLTCatalent Inc
0.91%44.442.4%$39.76m
HZNPHorizon Pharma plc
2.98%25.266.7%$35.55m
PTLAPortola Pharmaceuticals, Inc.
2.76%35.407.6%$33.06m
ICLRICON Plc
3.89%135.054.1%$30.66m
ZYNEZynerba Pharmaceuticals Inc
4.21%9.908.3%$28.70m
MYOKMyoKardia, Inc.
2.06%49.072.4%$25.77m
MNKMallinckrodt Plc
3.15%18.3621.0%$25.24m

Company Profile

Harrow Health, Inc. engages in the development, production, and sale of innovative medications. It operates through the Pharmaceutical Compounding and Pharmaceutical Drug Development segments. The Pharmaceutical Compounding segment focuses on the operations of ImprimisRx and Park Compounding businesses. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in San Diego, CA.